EARLY IMPACT OF MMAT-3 POLICY ON LIVER TRANSPLANT OUTCOMES FOR HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Shaikh, Anjiya T.
Rich, Nicole E.
Benhammou, Jihane N.
Goss, John A.
Kim, Donghee
Ahmed, Aijaz
Rana, Abbas
Lee, Tzu-Hao
Kanwal, Fasiha
Cholankeril, George T.
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
435
引用
收藏
页码：S1127 / S1127
页数：1
相关论文
共 50 条
  • [21] Liver Transplant and Hepatocellular Carcinoma
    Gish, Robert G.
    Clinical Advances in Hematology & Oncology, 2016, 14 (12) : 987 - 989
  • [22] The impact of loco-regional therapy on long term outcomes of liver transplant recipients for hepatocellular carcinoma
    Eshraghian, Ahad
    Taghavi, Alireza
    Nikeghbalian, Saman
    Nikoupour, Hamed
    Shamsaeefar, Alireza
    Malek-Hosseini, Seyed Ali
    TRANSPLANTATION, 2024, 108 (09) : 49 - 49
  • [23] Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
    Halazun, Karim J.
    Rosenblatt, Russell E.
    Mehta, Neil
    Lai, Quirino
    Hajifathalian, Kaveh
    Gorgen, Andre
    Brar, Gagan
    Sasaki, Kazunari
    Doyle, Maria B. Majella
    Tabrizian, Parissa
    Agopian, Vatche G.
    Najjar, Marc
    Ivanics, Tommy
    Samstein, Benjamin
    Brown, Robert S., Jr.
    Emond, Jean C.
    Yao, Francis
    Lerut, Jan
    Rossi, Massimo
    Mennini, Gianluca
    Iesari, Samuele
    Finkenstedt, Armin
    Schaefer, Benedikt
    Mittler, Jans
    Hoppe-Lotichius, Maria
    Quintini, Cristiano
    Aucejo, Federico
    Chapman, William
    Sapisochin, Gonzalo
    JAMA SURGERY, 2021, 156 (06) : 559 - 567
  • [24] Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
    Tabrizian, Parissa
    Holzner, Matthew L.
    Mehta, Neil
    Halazun, Karim
    Agopian, Vatche G.
    Yao, Francis
    Busuttil, Ronald W.
    Roberts, John
    Emond, Jean C.
    Samstein, Benjamin
    Brown, Robert S., Jr.
    Najjar, Marc
    Chapman, William C.
    Doyle, Majella Mb
    Florman, Sander S.
    Schwartz, Myron E.
    Llovet, Josep M.
    JAMA SURGERY, 2022, 157 (09) : 779 - 788
  • [25] Implications of Dynamic α-Fetoprotein on Outcomes Following Liver Transplant for Hepatocellular Carcinoma
    Ling, Xi Liang
    Han, Eun Young
    Chen, Zheyuan
    JAMA SURGERY, 2022, 157 (04) : 359 - 360
  • [26] Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma
    Kensinger, Clark D.
    Feurer, Irene D.
    O'Dell, Heather W.
    LaNeve, David C.
    Simmons, Lindsey
    Pinson, C. Wright
    Moore, Derek E.
    CLINICAL TRANSPLANTATION, 2016, 30 (09) : 1036 - 1045
  • [27] IMPACT OF MAJOR HEPATOCELLULAR CARCINOMA POLICY CHANGES ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Shah, Rahil Harshad
    Chyou, Darius
    Goldberg, David S.
    HEPATOLOGY, 2021, 74 : 59A - 59A
  • [28] Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States
    Shah, Rahil H.
    Chyou, Darius
    Goldberg, David S.
    LIVER TRANSPLANTATION, 2022, 28 (12) : 1857 - 1864
  • [29] THE IMPACT OF TRANSARTERIAL THERAPY IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANT
    Cabrera, Roniel
    Dhanasekaran, Renumathy
    Clark, Virginia
    Soldevila-Pico, Consuelo
    Morelli, Giuseppe Joseph
    Caridi, James G.
    Kim, Robin D.
    Limaye, Alpna R.
    Nelson, David R.
    Firpi, Roberto J.
    HEPATOLOGY, 2010, 52 (04) : 1154A - 1155A
  • [30] SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA (HCC) AND IMPACT ON MANAGEMENT AT A LIVER TRANSPLANT CENTER
    Smirniotopoulos, John
    Wright, Henry C.
    Nusbaum, Jeffrey D.
    Dash, Chiranjeev
    Varghese, Rency S.
    Satoskar, Rohit
    Laurin, Jacqueline
    Fishbein, Thomas
    Shetty, Kirti
    HEPATOLOGY, 2011, 54 : 1414A - 1415A
12345